|
Originally published In Press as doi:10.1074/jbc.M111952200 on July 22, 2002
J. Biol. Chem., Vol. 277, Issue 39, 36085-36091, September 27, 2002
Carbonic Anhydrase II Binds to and Enhances Activity of the
Na+/H+ Exchanger*
Xiuju
Li §,
Bernardo
Alvarez ¶,
Joseph R.
Casey ¶ ,
Reinhart A. F.
Reithmeier**, and
Larry
Fliegel  
From the Departments of Biochemistry and
¶ Physiology, Canadian Institute of Health Research Membrane
Protein Group, University of Alberta, Edmonton, Alberta T6G 2H7,
Canada, and the ** Canadian Institute of Health Research
Group in Membrane Biology, Department of Medicine and Biochemistry,
University of Toronto, Toronto, Ontario M5S 1A8, Canada
Received for publication, December 14, 2001, and in revised form, July 11, 2002
 |
ABSTRACT |
We examined the ability of carbonic anhydrase II
to bind to and affect the transport efficiency of the NHE1 isoform of
the mammalian Na+/H+ exchanger. The
C-terminal region of NHE1 was expressed in Escherichia coli fused with an N-terminal glutathionine
S-transferase or with a C-terminal polyhistidine tag. Using
a microtiter plate binding assay we showed that the C-terminal region
of NHE1 binds carbonic anhydrase II (CAII) and binding was stimulated
by low pH and blocked by antibodies against the C-terminal of NHE1. The
binding to NHE1 was confirmed by demonstrating protein-protein
interaction using affinity blotting with CAII and immobilized NHE1
fusion proteins. CAII co-immunoprecipitated with NHE1 from CHO cells
suggesting the proteins form a complex in vivo. In cells
expressing CAII and NHE1, the H+ transport rate was almost
2-fold greater than in cells expressing NHE1 alone. The CAII inhibitor
acetazolamide significantly decreased the H+ transport rate
of NHE1 and transfection with a dominant negative CAII inhibited NHE1
activity. Phosphorylation of the C-terminal of NHE1 greatly increased
the binding of CAII. Our study suggests that NHE1 transport
efficiency is influenced by CAII, likely through a direct interaction
at the C-terminal region. Regulation of NHE1 activity by
phosphorylation could involve modulation of CAII binding.
 |
INTRODUCTION |
The Na+/H+ exchanger
(NHE)1 is a ubiquitously
expressed integral membrane glycoprotein that functions to exchange one
intracellular proton for one extracellular sodium, thereby protecting
cells from intracellular acidification (1). Several known isoforms of
the Na+/H+ exchanger have been designated
NHE1-NHE7. NHE1 was the first isoform cloned (2) and is ubiquitously
expressed in the plasma membrane of mammalian cells, with the other
isoforms having more restricted tissue distributions (3). In mammals,
NHE1 plays a key role in regulation of cell pH, cell volume, and cell
proliferation (4). It is also critically involved in the damage that
occurs to the myocardium with ischemia and reperfusion (5).
The Na+/H+ exchanger (NHE1 isoform) consists of
two structural and functional domains, a 500 amino acid N-terminal
membrane domain that is responsible for ion transport, and a C-terminal cytoplasmic domain of ~300 amino acids that regulates activity of the
membrane domain (1). The large cytoplasmic domain is involved in
protein-protein interactions with a number of proteins including
calcineurin homologous protein (6), calmodulin (7), and heat shock
protein (8). In addition the Na+/H+ exchanger
is subject to regulation by phosphorylation that stimulates transport
activity (9).
Carbonic anhydrases catalyze the hydration of CO2 to
produce HCO and H+. The
predominant cytoplasmic isozyme is carbonic anhydrase II (CAII) (10).
CAII deficiency is associated with osteopetrosis, renal tubular
acidosis, and cerebral calcification (11). In the red blood cell, CA
activity is required for efficient
Cl /HCO exchange by the
anion exchanger AE1 (12). Recently it was discovered (13) that CAII
binds directly to AE1. The binding site was located in acidic residues (887DADD) of the C-terminal cytosolic region of AE1 (14).
The binding site for AE1 was localized to the basic N-terminal of CAII
(15).
Since the activity of CAII can result in proton production, an
association of CAII with the Na+/H+ exchanger
could facilitate proton removal. Several reports have supported the
notion that the Na+/H+ exchanger is in some way
associated with CA and AE. It was demonstrated earlier that the CA
inhibitor acetazolamide could result in a reduction of
Na+/H+ exchanger activity (16). The
Na+/H+ exchanger and the AE both localize to
the same protruding lamellipodium regions of some cell types (17).
Also, the AE has long been shown to be linked to the cytoskeleton (18),
and the Na+/H+ exchanger has also recently been
shown to be linked to the cytoskeleton (19). It is also interesting to
note that the presence of NHE1 has been shown to be essential for the
regulation or functional expression of
HCO -dependent and
-independent transporters in neurons (20), suggesting that AE and CA
interact with and may in some way be regulated by the
Na+/H+ exchanger. In this report we examine the
hypothesis that NHE1 binds to CAII. We demonstrate a direct interaction
of CAII with the Na+/H+ exchanger and give
evidence of effects on activity. The results support the hypothesis
that Na+/H+ exchanger activity is linked to
bicarbonate-based pH regulation possibly through carbonic anhydrase activity.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Restriction enzymes, E. coli BL21-SI,
pDest 17, and related GATEWAYTM cloning items were from
Invitrogen. pGEX-3X, glutathione-Sepharose 4B and protein A-Sepharose
CL-4B were from Amersham Biosciences. Glutathione, CAII protein (from
rabbit), nigericin, phenylenediamine, and acetazolamide were from
Sigma. Rabbit anti-human CAII polyclonal antibody was from Abcam Ltd,
(Cambridge, UK), and rabbit anti-hemagglutinin (HA) and Protein G-PLUS
agarose were from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit
anti-His tag antibody was purchased from BioWorld, Dublin, OH.
Conjugated antibodies were from Jackson ImmunoResearch (Mississauga,
Ont.). Ni-NTA-agarose resin was from Qiagen (Valencia, CA). -Casein
(dephosphorylated) was from Sigma and casein kinase II (human
recombinant) was from Cederlane laboratories (Hornby, Ont.). DSP
(dithiobis(succinimidylpropionate)) was purchased from Pierce.
Construction and Purification of
Na+/H+ Exchanger Fusion
Proteins--
The C-terminal 178 amino acid sequence of the rabbit
cardiac Na+/H+ exchanger was expressed as a
fusion protein with GST (GST178) using the plasmid pGEX-3X as described
previously (21). The E. coli TOPP2 strain was induced with 1 mM isopropylthiol- -D-galactoside. GST178
was purified via glutathione-Sepharose 4B affinity chromatography as
described earlier (21). The C-terminal 182 amino acids of the rabbit
Na+/H+ exchanger (NHE1) were expressed as a
fusion protein with a C-terminal histidine tag (His182) using the
plasmid pDest 17 and the GatewayTM Cloning System. The
E. coli strain BL21-SI strain was induced with 0.3 M NaCl for 3 h. His182 protein was purified via Ni-NTA affinity chromatography as described by the manufacturer (Qiagen).
Cell Culture and Transfections--
A Chinese hamster ovary cell
line (AP1 cells) that was previously selected to lack endogenous NHE
activity (22) was grown in a humidified atmosphere of 5%
CO2 and 95% air in -MEM medium supplemented with 10%
(v/v) fetal bovine serum, 25 mM HEPES, penicillin (100 units/ml), and streptomycin (100 µg/ml), pH 7.4 at 37 °C. Stable
transfections were made and selected by the calcium phosphate technique
essentially as described earlier (23). The plasmid pYN4+ contains the
HA-tagged NHE1 isoform of the human Na+/H+
exchanger (23), and the plasmid pJRC36 encodes human CAII (24). Both
were behind the constitutively active cytomegalovirus (CMV) promoter
and were used to stably transfect AP1 cells as described earlier (23).
Where indicated, transient transfections were used to introduce
plasmids as described earlier (24). For dominant negative experiments
an inactive mutant of CAII was used, which possessed the V143Y mutation
(24, 25).
Measurement of Intracellular pH--
NHE activity was measured
fluorometrically using 2',7 -bis(2-carboxyethyl)-5 (6)
carboxyfluorescein-AM (BCECF-AM) essentially as described previously
(26, 27). pH regulation by the Na+/H+ exchanger
was examined in (un- or mock-transfected) AP1 cells, AP1/pYN4+ stably
transfected cells and AP1/pYN4+/pJRC36 stably transfected cells. Cells
were grown on glass coverslips and the acetoxymethyl ester of BCECF-AM
was used to measure pHi. Cells on the coverslips were
incubated with BCECF-AM for 18 min at 37 °C and placed into a holder
device and inserted into a fluorescence cuvette at room temperature.
The cuvette was supplied with 5 mM HEPES buffer bubbled
with 100% O2 (pH 7.4 ± 0.5) with a constant flow of
3.5 ml/min and shifted into a buffer containing 25 mM HCO buffer whenever appropriate.
HCO solutions were bubbled with 5%
CO2, 95% air to create dissolved CO2 where
appropriate as described earlier (27). The intracellular pH was
measured using the dual excitation single emission ratio technique with
a PTI spectrofluorophotometer. Excitation wavelengths were 440 and 490 nm, and the emission wavelength was 520 nm. Acetazolmide (100 µM) was added into the buffer when indicated. A
calibration curve for intracellular dye was generated using the high
K+-nigericin technique for each coverslip (24). The
pH/min was calculated using Sigma plot software. The use of
CO2/HCO to acidify cells
for measurement of Na+/H+ exchanger activity
has been used earlier (28, 29).
Western Blot of Na+/H+
Exchanger and Carbonic Anhydrase--
AP1 cells transfected with pYN4+
or both pYN4+ and pJRC36 were grown in 60-mm Petri dishes. They were
treated with RIPA lysate buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, and
a proteinase inhibitor mixture) (8) to extract cellular proteins. Total
cell extracts were fractionated by 12% SDS-PAGE and transferred to
nitrocellulose as described earlier (8). Mouse monoclonal anti-HA tag
antibody (1:2000) and rabbit anti-human CAII antibody (1:50,000) were
used to check for the expression of transfected proteins.
To examine CAII binding to the Na+/H+ exchanger
immobilized on nitrocellulose, GST, GST178, and His182 proteins were
separated on 12% SDS-PAGE and then transferred to nitrocellulose
membranes (8). Nitrocellulose membranes were blocked with 10% (w/v)
skim milk powder in TBS (20 mM Tris, pH 7.4, 137 mM NaCl) for 5 h at 4 °C. They were then incubated
with 10 µg of CAII with 1% (w/v) skim milk powder in TBS and rocked
gently overnight at 4 °C. Membranes were washed with TBS for 4 × 15 min at room temperature. The nitrocellulose was then incubated
with rabbit anti-CAII antibody (1:50,000) in TBS with 1% skim milk
powder for 2 h at room temperature followed by washing for another
hour with TBS. Further amplification was achieved by a subsequent
incubation with goat anti-rabbit-horseradish peroxidase antibodies.
Reactive bands were visualized by the Amersham Biosciences Enhanced
Chemiluminescence system.
Co-immunoprecipition of NHE1 and CAII--
All steps were
performed at 4 °C unless otherwise noted. AP1 cells, AP1/pYN4+, and
AP1/pYN4+/pJRC36-transfected cells were washed with phosphate-buffered
saline (PBS, 150 mM NaCl, 5 mM sodium
phosphate, pH 7.4) and frozen in 2 ml of RIPA buffer in the absence of
detergent (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 80 mM NaF, 5 mM EDTA, 1 mM EGTA, 1 mM sodium orthovanadate, and proteinase inhibitor mixture)
by placing cells on dry ice. Cells were defrosted and removed from the
flask followed by sonication for 15 s. The lysate was centrifuged
(35,000 × g for 1 h), and the pellet containing
the Na+/H+ exchanger was resuspended and
sonicated for 15 s in 2 ml of RIPA buffer with detergent (1%
Nonidet P-40, 0.5% deoxychlolate). After centrifugation at 10,000 × g for 30 min, the supernatant was collected for
immunoprecipitation. The supernatant, containing
Na+/H+ exchanger, was rocked overnight with 7.5 µl of rabbit anti-HA tag polyclonal antibody. Protein A-Sepharose was
added, and the sample was incubated for a further 2 h. The resin
was washed with RIPA buffer, and bound protein was solubilized with
SDS-PAGE sample buffer. Proteins were transferred to nitrocellulose
after SDS-PAGE and probed with anti-CAII antibody. For some experiments
to obtain a more quantitative co-immunoprecipitation of CAII and the
Na+/H+ exchanger a cross-linking reagent was
used. DSP was added to cells at a final concentration of 2 mM for 30 min at room temperature. The reaction was
terminated by addition of Tris, pH 7.5, to a final concentration of 10 mM. Cells were then washed with phosphate-buffered saline,
and the immunoprecipitation was continued as described above.
Microtiter Plate Binding Assay--
Purified CAII (0.2 µg/well) was immobilized onto 96-well microtiter plates by overnight
incubation in buffer containing 1.25 mg/ml of
1-cyclohexyl-3-(2-morpholinoethy) carbodiimide
metho-p-toluene sulfonate in 150 mM NaCl, 100 mM sodium phosphate, pH 6.0 at 4 °C. Plates were then
washed extensively with PBST (150 mM NaCl, 5 mM
sodium phosphate, 0.1% Triton X-100, pH 7.5) and blocked for 1 h
at 37 °C in PBS with 0.5% bovine serum albumin. The bound CAII was
shown to be active by an esterase assay (13). Plates were washed with
PBST and incubated for 1 h with 0-100 nM GST178 or
His182 in Ab buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM EDTA, 0.1%
C12E8, 0.25% gelatin) at 37 °C. Purified
GST was used as a control. Plates were washed with PBST and incubated with rabbit anti-GST (1:4000) antibody or with anti-His tag antibody (1:2000) for 1 h at 37 °C. Plates were further washed, and goat anti-rabbit horse radish peroxidase (1:4000) antibody was added for
1 h at 37 °C. Red color was developed by 0.1%
o-phenylenediamine in substrate buffer (50 mM
citric acid, 5 mM sodium phosphate, pH 5.0, 0.09%
H2O2). The reaction was terminated with 50 µl
of 3 M H2SO4 per well, and
absorbance of microtiter plates was read at
A450. For some experiments the pH or incubation
time of Ab buffer was varied as indicated in the figure legends. In
other experiments an antibody against the C-terminal 178 amino acids of
the Na+/H+ exchanger (described earlier, Ref.
8) was premixed with His182 in the Ab buffer at the indicated
concentrations. This was then immediately incubated with immobilized
CAII.
In Vitro Phosphorylation of Proteins--
In some experiments
cell extracts from rabbit ventricular muscle were used to phosphorylate
the His182 fusion protein. Cell extracts and in vitro
phosphorylation of the His182 fusion protein were as described earlier
(9). In some cases primary cultures of isolated myocyte cells
were grown overnight in serum-free medium (unstimulated), as opposed to
serum-containing medium (stimulated) to reduce the activity of
NHE1-directed protein kinases as described earlier (9). After
phosphorylation (or mock phosphorylation of controls) by cell extracts
the Na+/H+ exchanger fusion protein (His182)
was removed from the cell extracts using Ni-NTA-linked agarose.
Phosphorylated and non-phosphorylated His182 proteins were used to
examine CAII binding to the Na+/H+ exchanger
immobilized on nitrocellulose as described above. To confirm that equal
amounts of phosphorylated and non-phosphorylated protein were present,
nitrocellulose transfers were examined by Ponceau S staining. Some
in vitro phosphorylation experiments contained
32P to confirm in vitro phosphorylation of the
protein. In these experiments the final ATP concentration was 250 µM. In experiments without 32P labeling the
final ATP concentration was 1 mM.
In some experiments we examined the binding of CAII to phosphorylated
and unphosphorylated casein. To phosphorylate casein (4 µg) was
treated with casein kinase 2 enzyme in a reaction consisting of 100 mM Tris-HCl, pH 8.0, 20 mM MgCl2,
50 mM KCl, 100 mM NaCl, 2.5 mM
EGTA, 0.2 mM EDTA, 3 mM ATP (or 1 µl of
[ -32P]ATP) and 1 µl of kinase (500 units/µl) for
30 min at 30 °C as described by others (30). Some in
vitro phosphorylation experiments contained 32P to
confirm in vitro phosphorylation of the protein.
Phosphorylated and unphosphorylated casein was then used to examine
CAII binding while immobilized on nitrocellulose as described above for
the Na+/H+ exchanger.
 |
RESULTS |
Protein Production and Purification--
To study the C-terminal
region of the Na+/H+ exchanger it was produced
as two independent fusion proteins. The fusion proteins contained amino
acids 635-816 or 639-816, respectively, of the rabbit NHE1 protein
with histidine and GST tags respectively. The identities of the induced
proteins were confirmed using an antibody generated against the
C-terminal region of Na+/H+ exchanger (not
shown) (8). The proteins were purified using the standard procedures
with either glutathione-Sepharose or Ni-NTA affinity chromatography.
Na+/H+ Exchanger Binding to
CAII--
A solid phase binding assay was used to examine the
interaction between the C terminus of the
Na+/H+ exchanger (GST178, His182) and CAII.
CAII was immobilized on microtiter plates and possessed enzymatic
activity indicating it had retained a native conformation (13). The
binding curves of GST178, His182 and GST to immobilized CAII (Fig.
2A) showed that the amount of GST178 and His182 binding
increased with increasing concentrations and saturated at higher
levels. Under the identical conditions, only a low background binding
to GST was observed, suggesting the binding was caused by the
Na+/H+ exchanger part of the molecules. There
was no indication of cooperatively from the shape of the curve. We
tested the effect of varying the pH of the incubation medium
on the interaction between CAII and NHE1. The results (Fig.
1B) showed that in acidic
medium the interaction between NHE1 and CAII was increased. A time
course (Fig. 1C) of the interaction between NHE1 and CAII
showed that the association was time-dependent reaching
saturation in 30 min. To confirm that the interaction was specifically
due to the association between the C terminus of NHE1 and CAII we used
an antibody generated against an independently made, different fusion
protein of NHE1 directed toward the C-terminal 178 amino acids
(8). The results (Fig. 2D)
showed that this antibody blocked the association of CAII with
NHE1.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Solid phase microtiter plate binding assay
for Na+/H+ exchanger and CAII
interactions. CAII was immobilized to microtiter plates as
described under "Experimental Procedures." The fusion protein
concentration was 20 nM (B-D).
A, increasing concentrations of GST178, His182, or GST
proteins were added to CAII immobilized to microtiter plates. Bound
proteins were detected with anti-GST antibody or anti-His tag antibody.
B, effect of varying the pH of interaction medium on
interaction of NHE1 fusion proteins with immobilized CAII (0.2 µg/well). C, effect of varying the time of incubation
between CAII and NHEI fusion proteins. D, inhibition of
CAII and NHE1 interaction by addition of varying amounts of anti-NHE1
antibody. Results are mean ± S.E. of at least four
experiments.
|
|

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 2.
Affinity blotting assay of CAII with
Na+/H+ exchanger fusion proteins. Fusion
proteins were separated with SDS-PAGE and transferred to
nitrocellulose. Lanes 1-3 are 10 µg of the proteins
GST178, His182, and GST proteins. A, nitrocellulose
transfer of proteins probed with CAII. B, Coommassie
Blue stain of corresponding proteins in SDS-PAGE. Results are typical
of three experiments.
|
|
To confirm the results of the solid phase assay we used an affinity
blotting technique. Equal amounts (10 µg) of purified GST178, His182,
or GST were run on SDS-PAGE, transferred to nitrocellulose membranes,
and probed with CAII. The results (Fig. 2) showed that both the
His-tagged and the GST-tagged Na+/H+ exchanger
C-terminal proteins (GST178 and His182) bound CAII. Purified GST alone
did not bind CAII.
In Vivo Interactions of CAII and NHE1--
To determine if the
Na+/H+ exchanger can interact with CAII
in vivo we made stable cell lines of AP1 cells expressing
the Na+/H+ exchanger (pYN4+) alone or cells
expressing the Na+/H+ exchanger plus CAII
(pYN4+/pJRC36). Fig. 3 illustrates the
analysis of the cell lines. Fig. 3A demonstrates the
presence of the Na+/H+ exchanger protein in
cells lines transfected with HA-tagged Na+/H+
exchanger protein. We usually found a larger form of the NHE1 protein
of ~105-110 kDa plus a smaller form about 90-95 kDa in size. This
result is commonly found with the smaller isoform representing unglycosylated or partially glycosylated protein (26, 31). Fig. 3,
B and C, demonstrate the presence of CAII and
Na+/H+ exchanger, respectively, in cells stably
co-transfected with pYN4+/pJRC36 plasmids. To examine if an interaction
between CAII and the Na+/H+ exchanger occurs
in vivo, co-transfected actively growing cells were used for
immunoprecipitation with anti-HA antibody. Fig. 3D
illustrates the results of immunoblotting of the immunoprecipitates. Lanes 1 and 2 contained CAII immunoreactive
protein of the same size as purified CAII protein (lane 4).
Lane 3 contained immunoprecipitates of untransfected AP1
cells and did not show any CAII immunoreactive species. The results
show that a complex of CAII and NHE1 can be isolated from
co-transfected cells. In this experiment we did not use a cross-linker
to secure the CAII to the Na+/H+ exchanger, and
therefore the results could be described qualitatively only.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 3.
Immunoblot of NHE1 and CAII in cell lines
stably transfected with Na+/H+
exchanger and CAII. A, immunoblot with anti-HA
antibody (directed against the HA tag of the
Na+/H+ exchanger). Lane 1,
mock-transfected AP1 cells. Lane 2, AP1 cells transfected
with the pYN4+ plasmid containing HA-tagged
Na+/H+ exchanger (NHE1).
Arrow indicates the position of the 105-110 kDa NHE1
immunoreactive band. B, immunoblot probed with anti-CAII
antibody. Lane 1, mock-transfected AP1 cells. Lane
2, AP1 cells transfected with the pYN4+ plasmid containing
HA-tagged Na+/H+ exchanger (NHE1) and pJRC36
containing CAII. Lane 3, positive control, 1 µg of
purified CAII protein. Arrow indicates the position of the
CAII immunoreactive bands. C, immunoblot probed with anti-HA
antibody. Lane 1, mock-transfected AP1 cells. Lane
2, AP1 cells transfected with the pYN4+ plasmid containing
HA-tagged Na+/H+ exchanger (NHE1)
and pJRC36 containing CAII. Arrow indicates the position of
the major 105-110-kDa NHE1 immunoreactive band. D,
immunoblot probed with anti-CAII antibody of immunoprecipitates. The
immunoprecipitation was with anti-HA antibody. Lane 1, AP1
cells transfected with the pYN4+ plasmid (alone) containing the
Na+/H+ exchanger. Lane 2, AP1 cells
transfected with pYN4+ and pJRC36 plasmids containing the
Na+/H+ exchanger and CAII respectively.
Lane 3, mock-transfected AP1 cells. Lane 4,
positive control, 1 of µg purified CAII protein. Arrow
indicates the position of the CAII immunoreactive bands.
|
|
Physiologic Effects of CAII on
Na+/ AH+ Exchanger
Activity--
To determine if CAII binding influences the activity
of the Na+/H+ exchanger we examined pH
regulation in AP1, AP1/pYN4+, and AP1/pYN4+/pJRC36 cells. Fig.
4A illustrates examples of the
effects obtained during transient induction of acid load by shifting
cells from 02-gassed nominally CO2-free medium
to CO2/HCO -containing medium as described by others (27-29). AP1 cells, lacking the
Na+/H+ exchanger, showed only very small
amounts of alkalization (recovery) after acid load. Stably transfected
AP1/pYN4+ cells showed a much greater recovery (Fig. 4A),
indicating that the Na+/H+ exchanger extruded
H+s and alkalinized the cells. The results shown were
typical of several independently made cell lines. Stable transfectants
of AP1/pYN4+/pJRC36 cells also alkalinized after acid load; however, their recovery was faster than AP1/pYN4+ cells, indicating that cotransfection of CAII with NHE1 stimulated H+ transport by
the Na+/H+ exchanger (Fig. 4A). This
effect was reduced by treatment with acetazolamide. Fig. 4B
summarizes these results. The amiloride analogue
5-(N,N-hexamethylene)-amiloride inhibited the recovery indicating that it was due to the Na+/H+
exchanger (not shown). Fig. 4B also shows that treatment
with the CA inhibitor acetazolamide can affect
Na+/H+ exchanger activity of (AP1/pYN4+). The
H+ transport rate of AP1/NHE1 cells was reduced 37 ± 7.8% (n = 5) when cells were treated with 100 µM acetazolamide (Fig. 4B). Acetazolamide also
reduced the transport rate of AP1/NHE1/CAII cells by 74% (n = 5). To confirm that a direct interaction between
CAII and NHE1 was necessary for stimulation of NHE1 activity, we
transiently transfected the dominant negative CAII mutant with a V143Y
mutation into AP1/pYN4+ cells. We found that this resulted in
approximately a 50% decrease in NHE1 activity (Fig. 4C,
n = 4) likely due to displacement of endogenous CAII
from its binding site on NHE1. Transfection with equivalent amount of
vector without CAII had no effect on NHE1 activity (not shown).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 4.
Effects of CAII expression and acetazolamide
on H+ transport rate of AP1 cells in the presence of
bicarbonate. Cell lines were initially bathed in O2
bubbled HEPES-containing buffer (pH 7.4 ± 0.5) and then shifted
to CO2/HCO -containing
buffer to create a bicarbonate-dependent acid load. The
rate of recovery from an acid load was quantified as described earlier
(27). A, examples of effects on intracellular pH.
Representative effects on rate of recovery from an acid load induced by
CO2/HCO are illustrated.
AP1 refers to AP1 cells that do not have an endogenous
Na+/H+ exchanger. AP1/NHE1 refers to
AP1 cells stably transfected with the plasmid pYN4+ that expresses the
Na+/H+ exchanger (NHE1). AP1/pYN4+/CAII are AP1
cells stably transfected with NHE1 and the plasmid pJRC36 that
expresses CAII. ACTZ indicates that the appropriate cells were treated
with 100 µM acetazolamide. B, summary of
H+ transport rates of Na+/H+
exchanger and Na+/H+ exchanger and
CAII-transfected cells. Results are mean ± S.E. of at least seven
experiments. Abbreviations are as in A. Asterisk
indicates statistically significant difference from AP1/NHE1 cells at
p < 0,05. C, effect of dominant negative
CAII with a V143Y mutation on Na+/H+ exchanger
activity of AP1 cells. AP1 cells stably transfected with NHE1 were
transiently transfected with either empty vector
(AP1/NHE1) or CAII with a V143Y mutation
(AP1/NHE1/CAV143Y). The activity of
NHE1 was measured as described in the legend for Fig. 4. Results are
mean ± S.E. of four experiments.
|
|
Effects of Phosphorylation on CAII Binding to NHE1--
Because
phosphorylation of NHE1 has been shown to be stimulatory to activity
(9) we examined if phosphorylation could influence the binding of CAII
to the C-terminal of NHE1. Fig.
5A (lane 1) confirms that cell extracts from rabbit ventricles phosphorylate the
His182 fusion protein. As a control, we also phosphorylated commercially obtained casein, using casein kinase II (lane
3). We then examined the effect of phosphorylation of CAII
binding. Fig. 5B compares the binding of CAII to equal
amounts of phosphorylated (lane 1) and
non-phosphorylated (lane 2) His182 protein and
phosphorylated (lane 3) and non-phosphorylated (lane
4) casein. Phosphorylated NHE1 C-terminal protein bound much
larger amounts of CAII than unphosphorylated protein. The effect was
seen in over seven independent experiments with the His182 protein.
Phosphorylation of the NHE1 protein also caused a slight mobility shift
in the protein typical of proteins with added phosphate moieties.
Neither phosphorylated or non-phosphorylated casein bound CAII. To
compare the effect of different amounts of phosphorylation activity
from cells we examined the effects of isolated myocyte extracts treated
or untreated with serum as described under "Experimental
Procedures." Fig. 5C shows that unstimulated extracts
phosphorylated the His182 protein to a lesser degree than stimulated
extracts. The same extracts were used to treat the His182 protein and
then the binding of CAII was examined. The results are shown in Fig.
5D. Extracts from active, stimulated cells that caused a
higher degree of phosphorylation (lanes 2 and
4, stimulated), resulted in greater binding
of the CAII protein to His182 than cells that caused a lesser degree of
phosphorylation (lanes 1 and 3). The amount of
increase in CAII binding by increased levels of phosphorylation was
between 45 and 60% in three different experiments. To examine the
effect of phosphorylation in vivo on the binding of CAII to
the Na+/H+ exchanger we used a cross-linking
reagent, DSP, to make the linkage between the two proteins more stable
and more quantitative during the immunoprecipitation process. DSP
contains a thiol-cleavable linkage, and the samples were incubated in
SDS-PAGE sample buffer containing -mercaptoethanol prior to
electrophoresis. The results are shown in Fig. 5E.
Lanes 2 and 3 illustrate immunoprecipitated CAII
from cells transfected with Na+/H+ exchanger
and CAII. The amount immunopreciptated from cells in the presence of
serum (lane 2) was always greater than that in the absence
of serum (lane 3). Lanes 4 and 5 illustrate a similar experiment but with cells transfected with only
the Na+/H+ exchanger. More CAII
immunoprecipited in the presence of serum (lane 4) than in
its absence (lane 5). In addition the amount of CAII
immunoprecipitated in these cells in the presence of serum (lane
4) was reduced by about 40%, compared with cells transfected with
additional CAII (lane 2). In the absence of serum there was no difference in the amount immunoprecipitated from cells transfected with or without exogenous CAII, and this amount was always small, about
25-35% of the amount of CAII immunoprecipitated from serum-stimulated cells. Reprobing the immunoblot with anti-HA antibody demonstrated that
the equivalent amount of Na+/H+ exchanger was
present in lanes 2-5 (not shown).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of phosphorylation on CAII
binding to the Na+/H+ exchanger.
A-D, purified His182 protein was incubated with ATP and a
cell lysate prepared from rabbit ventricular myocardium.
A, autoradiogram of His182 fusion protein
and casein phosphorylated in the presence of
[ -32P]ATP. Arrow denotes the phosphorylated
His182 protein. The His182 fusion protein containing the C-terminal 182 amino acids of the Na+/H+ exchanger was
phosphorylated in vitro with rabbit ventricular cell
extracts, and casein was phosphorylated with casein kinase II as
described under "Experimental Procedures." Lane 1,
His182 protein phosphorylated with cell extracts. Lane 2,
His182 protein treated with the presence of phosphorylating buffer but
in the absence of cell extracts. Lane 3, casein treated with
casein kinase II in a phosphorylating buffer. Lane 4, casein
treated with phosphorylating buffer in the absence of kinase.
B, affinity blotting assay of phosphorylated and
non-phosphorylated proteins. Equal amounts of His182 and casein
proteins were separated by SDS-PAGE and transferred to nitrocellulose
as described under "Experimental Procedures." Nitrocellulose
transfer of proteins was probed with CAII protein as described in the
legend to Fig. 2. Lanes are as described for Fig. 5. The
arrow indicates location of CAII binding to His182.
C, autoradiogram of phosphorylation of the His182
protein by unstimulated (lanes 1 and 2) and
stimulated (lanes 3 and 4) rat cardiomyocyte
extracts prepared as described under "Experimental Procedures."
D, affinity blotting assay of phosphorylated His182
fusion protein treated with unstimulated (lanes 1 and
3) and stimulated (lanes 2 and 4) rat
cardiomyocyte extracts. Equal amounts of His182 proteins were separated
by SDS-PAGE and transferred to nitrocellulose as described under
"Experimental Procedures." Nitrocellulose transfer of proteins was
probed with CAII protein as described in the legend to Fig. 2. Results
are typical of three independent experiments. E,
immunoblot of immunoprecipitates probed with anti-CAII antibody. The
immunoprecipitation was with anti-HA antibody. Samples were treated
with DSP prior to immunoprecipitation and were finally heated in sample
buffer containing -mercaptoethanol as described under
"Experimental Procedures." Lane 1, positive control, 1 µg of purified CAII protein. Lanes 2 and 3,
immunoprecipitate from cells transfected with pYN4+ and pJRC36
plasmids. Lanes 4 and 5, immunoprecipitate from
cells transfected with pYN4+. Lanes 2 and 4,
immunoprecipitate from cells grown in the presence of serum.
Lanes 3 and 5, immunopreciptate from cells grown
in the absence of serum for 16 h.
|
|
 |
DISCUSSION |
The Na+/H+ exchanger is an essential part
of pH homeostasis in mammalian cells. Regulation of the
Na+/H+ exchanger has been the subject of many
investigations but is still not well understood at the molecular level.
The C-terminal, hydrophilic domain of Na+/H+
exchanger regulates the activity of the membrane domain that transports
the Na+ and H+ ions (4, 32). The cytoplasmic,
C-terminal of the exchanger is over 300 amino acids in length and can
be divided into four distinct subdomains that are involved in
regulation. These include an ATP-dependent regulation,
phosphorylation region, and binding regions for calcineurin homologous
protein and calmodulin (1). It is still unclear if there are other
proteins involved in the interactions of the C-terminal of the
Na+/H+ exchanger.
Recently, it was found that CAII could interact with the C-terminal of
the anion exchanger by binding with an acidic amino acid cluster
(887DADD) (13, 14). Removal of the DADD sequence resulted
in a loss of CAII binding (14). The binding may allow the formation of
a metabolon between AEI and CAII that functions to channel the products
of the carbonic anhydrase reaction to the anion exchanger (25, 33).
Several observations suggested that CAII might also associate with the
Na+/H+ exchanger. First, there is a general
structural and functional similarity between the anion exchanger and
Na+/H+ exchanger, with both proteins having
large interior cytoplasmic domains with internal acidic amino acids.
Second, several reports have suggested that the
Na+/H+ exchanger is associated with CA and AEs
(16, 20, 34). Third, since CA catalyzes the hydration of
CO2 to produce a proton and bicarbonate, it might also
co-localize with NHE1 to improve efficiency of proton removal, similar
to CAII and the AE. It is of note that the C-terminal 178 amino acids
of NHE1 contain 12 aspartate and 17 glutamate residues that could be
involved in forming a binding site for CAII.
Our study demonstrated that the C-terminal 178 amino acids of NHE1
can bind CAII in microtiter plate binding assays and in affinity
blotting assays with immobilized Na+/H+
exchanger (Figs. 1 and 2). It was clear that the
Na+/H+ exchanger part of these fusion proteins
was responsible for the binding since GST alone did not bind to CAII.
CAII was found co-imunoprecipitating with the
Na+/H+ exchanger from cells either transfected
or not transfected with CAII (Fig. 3D). However the AP1
cells we used in this study possessed endogenous CAII (Fig.
3B, lane 1). Overall our results clearly indicate
an interaction between CAII and the Na+/H+
exchanger both in vivo and in vitro.
To examine the effects of CAII binding on
Na+/H+ exchanger activity in vivo,
pH regulation of transfected cells was measured. Our results showed
that cells transfected with both Na+/H+
exchanger and CAII have a higher H+ transport rate compared
with cells transfected with Na+/H+ exchanger
alone. The H+ transport rate in cotransfected cells
increased 76%, which suggests that CAII could stimulate
Na+/H+ exchanger activity. In addition, the
CAII inhibitor acetazolamide significantly decreased the H+
transport rates by the Na+/H+ exchanger. This
result further demonstrated that CAII activity influences activity of
the Na+/H+ exchanger. It was notable that
transfection with a dominant negative inactive carbonic anhydrase
mutant resulted in a decrease in activity of the
Na+/H+ exchanger protein (Fig. 4C).
Overexpression of a dominant negative CAII would cause displacement of
endogenous CAII from its binding site on NHE1 by the inactive CAII
mutant. Therefore we interpret the inhibitory effect of V143Y CAII on
the Na+/H+ exchanger activity as an indication
that direct binding by an active CAII protein is necessary for
stimulatory activity.
Phosphorylation of the Na+/H+ exchanger has
been shown to stimulate activity in the heart and other tissues.
Phosphorylation has also been localized to the C-terminal 178 amino
acids of the protein (9) similar to the region that we found binds
CAII. We found that phosphorylation of the
Na+/H+ exchanger greatly increased CAII binding
(Fig. 5). The effect was specific to CAII since phosphorylation of
casein did not result in CAII binding. The effect of phosphorylation
occurred in vitro, and we also found that serum treatment of
cells increases the amount of CAII that co-immunoprecipitated with the
Na+/H+ exchanger (Fig. 5E). We have
earlier shown that such serum stimulation causes phosphorylation of the
Na+/H+ exchanger in vivo (9). Since
phosphorylation has been shown to stimulate the activity of the
Na+/H+ exchanger, and since we found that
expression of CAII protein stimulated Na+/H+
exchanger activity, this leaves open the possibility that the mechanism
by which phosphorylation stimulates the activity is through increased
CAII binding. However at present, this only remains a theory and
further experiments are necessary to explore this possibility. It is
interesting to note that the pH dependence of interaction of CAII with
the Na+/H+ exchanger (Fig. 1B) is
consistent with the known activity profile of NHE1, which is activated
by decreases in intracellular pH.
In summary, our results show that CAII can bind to the C-terminal of
the Na+/H+ exchanger in vitro and
in vivo. The interaction can influence pH regulation of
Na+/H+ exchanger in mammalian cells. Where CAII
binds on the C-terminal of Na+/H+ exchanger and
how CAII interacts with Na+/H+ exchanger
remains undefined. Further experiments are necessary to define the
binding site of CAII. Our results support the earlier suggestions that
CAII, the AE, and Na+/H+ exchanger activity may
be linked together in a functional complex or metabolon involved in
intracellular bicarbonate and pH regulation (20, 34). Future
experiments will further explore this possibility and the regulatory
role that phosphorylation plays in protein-protein interactions that
modulate Na+/H+ exchanger activity.
 |
ACKNOWLEDGEMENT |
We thank B. Booth for technical assistance.
 |
FOOTNOTES |
*
This work was supported by grants from the Canadian
Institute of Health Research (to L. F., J. R. C. and R. R.) and by
a grant from the Heart and Stroke Foundation of Canada (to L. F.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by the China Scholarship Council and the Henan Vocation
Technical Teachers College.
Supported by the Alberta Heritage Foundation for Medical Research.

To whom correspondence should be addressed: 347 Medical Science
Bldg., Dept. of Biochemistry, University of Alberta, Edmonton, Alberta
T6G 2H7, Canada. Tel.: 780-492-1848; Fax: 780-492-0886; E-mail:
lfliegel@ualberta.ca.
Published, JBC Papers in Press, July 22, 2002, DOI 10.1074/jbc.M111952200
 |
ABBREVIATIONS |
The abbreviations used are:
NHE, Na+/H+ exchanger;
CAII, carbonic anhydrase II;
NTA, nitrilotriacetic acid;
MEM, minimum essential medium;
HA, hemagglutinin;
RIPA, radioimmune precipitation assay buffer;
TBS, Tris-buffered saline;
PBS, phosphate-buffered saline;
Ab, antibody;
DSP, dithiobis(succinimidylpropionate).
 |
REFERENCES |
| 1.
|
Fliegel, L.
(2001)
Basic Res. Cardiol.
96,
301-305[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Sardet, C.,
Franchi, A.,
and Pouysségur, J.
(1989)
Cell
56,
271-280[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Counillon, L.,
and Pouyssegur, J.
(2000)
J. Biol. Chem.
275,
1-4[Free Full Text]
|
| 4.
|
Wiebe, C. A.,
DiBattista, E. R.,
and Fliegel, L.
(2001)
Biochem. J.
357,
1-10[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Avkiran, M.
(2001)
Basic Res. Cardiol.
96,
306-311[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Lin, X.,
and Barber, D. L.
(1996)
J. Biol. Chem.
93,
12631-12636
|
| 7.
|
Wakabayashi, S.,
Ikeda, T.,
Iwamoto, T.,
Pouyssegur, J.,
and Shigekawa, M.
(1997)
Biochemistry
36,
12854-12861[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Silva, N. L. C. L.,
Haworth, R. S.,
Singh, D.,
and Fliegel, L.
(1995)
Biochemistry
34,
10412-10420[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Moor, A. N.,
and Fliegel, L.
(1999)
J. Biol. Chem.
274,
22985-22992[Abstract/Free Full Text]
|
| 10.
|
Sly, W. S.,
and Hu, P. Y.
(1995)
Annu. Rev. Biochem.
64,
375-601[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Sly, W. S.,
Whyte, M. P.,
Sundaram, V.,
Tashian, R. E.,
Hewett-Emmett, D.,
Guibaud, P.,
Vainsel, M.,
Baluarte, H. J.,
Grushkin, A., Al-,
Mosawi, M.,
Sakati, N.,
and Ohlsson, A.
(1985)
N. Eng. J. Med.
313,
139-145[Abstract]
|
| 12.
|
Cousin, J. L.,
Motais, R.,
and Sola, F.
(1975)
J. Physiol. (London)
253,
385-399[Abstract/Free Full Text]
|
| 13.
|
Vince, J. W.,
and Reithmeier, R. A. F.
(1998)
J. Biol. Chem.
273,
28430-28437[Abstract/Free Full Text]
|
| 14.
|
Vince, J. W.,
and Reithmeier, R. A. F.
(2000)
Biochemistry
39,
5527-5533[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Vince, J. W.,
Carlsson, U.,
and Reithmeier, R. A.
(2000)
Biochemistry
39,
13344-13349[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Wu, Q.,
Pierce, W. M., Jr.,
and Delamere, N. A.
(1998)
J. Membr. Biol.
162,
31-38[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Klein, M.,
Seeger, S. B.,
Alper, S. L.,
and Schwab, A.
(2000)
J. Gen. Physiol.
115,
599-607[Abstract/Free Full Text]
|
| 18.
|
Davis, L. H.,
Otto, E.,
and Bennett, V.
(1991)
J. Biol. Chem.
266,
11163-11169[Abstract/Free Full Text]
|
| 19.
|
Denker, S. P.,
Huang, D. C.,
Orlowski, J.,
Furthmayr, H.,
and Barber, D. L.
(2000)
Mol. Cell
8,
1425-1436
|
| 20.
|
Yao, H., Ma, E., Gu, X.-Q.,
and Haddad, G. G.
(1999)
J. Clin. Invest.
104,
637-645[Medline]
[Order article via Infotrieve]
|
| 21.
|
Wang, H.,
Silva, N. L. C. L.,
Lucchesi, P. A.,
Haworth, R.,
Wang, K.,
Michalak, M.,
Pelech, S.,
and Fliegel, L.
(1997)
Biochemistry
36,
9151-9158[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Rotin, D.,
Steele-Norwood, D.,
Grinstein, S.,
and Tannock, I.
(1989)
Cancer Res.
49,
205-211[Abstract/Free Full Text]
|
| 23.
|
Murtazina, BR.,
Booth, B. J.,
Bullis, B. L.,
Singh, D. N.,
and Fliegel, L.
(2001)
Eur. J. Biochem.
268,
1-13[Medline]
[Order article via Infotrieve]
|
| 24.
|
Sterling, D.,
and Casey, J. R.
(1999)
Biochem. J.
344,
221-229
|
| 25.
|
Sterling, D.,
Reithmeier, R. A. F.,
and Casey, J. R.
(2001)
J. Biol. Chem.
276,
47886-47894[Abstract/Free Full Text]
|
| 26.
|
Wang, H.,
Singh, D.,
and Fliegel, L.
(1998)
Arch. Biochem. Biophys.
358,
116-124[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Tang, X.-B.,
Kovacs, M.,
Sterling, D.,
and Casey, J. R.
(1999)
J. Biol. Chem.
274,
3557-3564[Abstract/Free Full Text]
|
| 28.
|
Perez, N. G.,
Alvarez, B. V.,
Camilion de Hurtado, M. C.,
and Cingolani, H. E.
(1995)
Circ. Res.
77,
1192-1200[Abstract/Free Full Text]
|
| 29.
|
Murray, G. M. M. J.,
Trumble, W.,
and Magnuson, B. A.
(2001)
BioTechniques
30,
1036-1041[Medline]
[Order article via Infotrieve]
|
| 30.
|
Landesman-Bollag, E.,
Romieu-Mourez, R.,
Song, D. H.,
Sonenshein, G. E.,
Cardiff, R. D.,
and Seldin, D. C.
(2001)
Oncogene
20,
3247-3257[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Noel, J.,
Roux, D.,
and Pouyssegur, J.
(1996)
J. Cell Sci.
109,
929-939[Abstract]
|
| 32.
|
Fliegel, L.
(1999)
J. Thromb. Thrombolysis
8,
9-14[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Reithmeier, RA.
(2001)
Blood Cells Mol. Dis.
27,
85-89[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Mason, M. J.,
Smith, J. D.,
Garcia-Soto, J. J.,
and Grinstein, S.
(1989)
Am. J. Physiol.
256,
C428-C433[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Shahidullah, C.-H. To, R. M. Pelis, and N. A. Delamere
Studies on Bicarbonate Transporters and Carbonic Anhydrase in Porcine Nonpigmented Ciliary Epithelium
Invest. Ophthalmol. Vis. Sci.,
April 1, 2009;
50(4):
1791 - 1800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. K. Hoffmann, I. H. Lambert, and S. F. Pedersen
Physiology of Cell Volume Regulation in Vertebrates
Physiol Rev,
January 1, 2009;
89(1):
193 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Grenier, K. Abu-ihweij, G. Zhang, S. M. Ruppert, R. Boohaker, E. R. Slepkov, K. Pridemore, J.-J. Ren, L. Fliegel, and A. R. Khaled
Apoptosis-induced alkalinization by the Na+/H+ exchanger isoform 1 is mediated through phosphorylation of amino acids Ser726 and Ser729
Am J Physiol Cell Physiol,
October 1, 2008;
295(4):
C883 - C896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Becker and J. W. Deitmer
Nonenzymatic Proton Handling by Carbonic Anhydrase II during H+-Lactate Cotransport via Monocarboxylate Transporter 1
J. Biol. Chem.,
August 1, 2008;
283(31):
21655 - 21667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-S. Jung, H.-Y. Kim, J. Kim, M.-G. Lee, J. Pouyssegur, and E. Kim
Physical Interactions and Functional Coupling between Daxx and Sodium Hydrogen Exchanger 1 in Ischemic Cell Death
J. Biol. Chem.,
January 11, 2008;
283(2):
1018 - 1025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gonzalez-Begne, T. Nakamoto, H.-V. Nguyen, A. K. Stewart, S. L. Alper, and J. E. Melvin
Enhanced Formation of a Formula Transport Metabolon in Exocrine Cells of Nhe1 / Mice
J. Biol. Chem.,
November 30, 2007;
282(48):
35125 - 35132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Weise, H. M. Becker, and J. W. Deitmer
Enzymatic Suppression of the Membrane Conductance Associated with the Glutamine Transporter SNAT3 Expressed in Xenopus Oocytes by Carbonic Anhydrase II
J. Gen. Physiol.,
July 30, 2007;
130(2):
203 - 215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xue, D. Zhou, H. Yao, O. Gavrialov, M. J. McConnell, B. D. Gelb, and G. G. Haddad
Novel functional interaction between Na+/H+ exchanger 1 and tyrosine phosphatase SHP-2
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2007;
292(6):
R2406 - R2416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wang, J. Hu, I. A. Bobulescu, T. A. Quill, P. McLeroy, O. W. Moe, and D. L. Garbers
A sperm-specific Na+/H+ exchanger (sNHE) is critical for expression and in vivo bicarbonate regulation of the soluble adenylyl cyclase (sAC)
PNAS,
May 29, 2007;
104(22):
9325 - 9330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Becker and J. W. Deitmer
Carbonic Anhydrase II Increases the Activity of the Human Electrogenic Na+/Formula Cotransporter
J. Biol. Chem.,
May 4, 2007;
282(18):
13508 - 13521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. E. Cingolani and I. L. Ennis
Sodium-Hydrogen Exchanger, Cardiac Overload, and Myocardial Hypertrophy
Circulation,
March 6, 2007;
115(9):
1090 - 1100.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. V. Alvarez, D. E. Johnson, D. Sowah, D. Soliman, P. E. Light, Y. Xia, M. Karmazyn, and J. R. Casey
Carbonic anhydrase inhibition prevents and reverts cardiomyocyte hypertrophy
J. Physiol.,
February 15, 2007;
579(1):
127 - 145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Piermarini, E. Y. Kim, and W. F. Boron
Evidence against a Direct Interaction between Intracellular Carbonic Anhydrase II and Pure C-terminal Domains of SLC4 Bicarbonate Transporters
J. Biol. Chem.,
January 12, 2007;
282(2):
1409 - 1421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Becker, D. Hirnet, C. Fecher-Trost, D. Sultemeyer, and J. W. Deitmer
Transport Activity of MCT1 Expressed in Xenopus Oocytes Is Increased by Interaction with Carbonic Anhydrase
J. Biol. Chem.,
December 2, 2005;
280(48):
39882 - 39889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wroblewski, S. Spalthoff, U.-J. Zimmerman, R. L. Post, J. W. Sanger, and R. E. Forster
The role of carbonic anhydrase in the recovery of skeletal muscle from anoxia
J Appl Physiol,
August 1, 2005;
99(2):
488 - 498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Esbaugh, S. F. Perry, M. Bayaa, T. Georgalis, J. Nickerson, B. L. Tufts, and K. M. Gilmour
Cytoplasmic carbonic anhydrase isozymes in rainbow trout Oncorhynchus mykiss: comparative physiology and molecular evolution
J. Exp. Biol.,
May 15, 2005;
208(10):
1951 - 1961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Purkerson and G. J. Schwartz
Expression of membrane-associated carbonic anhydrase isoforms IV, IX, XII, and XIV in the rabbit: induction of CA IV and IX during maturation
Am J Physiol Regulatory Integrative Comp Physiol,
May 1, 2005;
288(5):
R1256 - R1263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Baumgartner, H. Patel, and D. L. Barber
Na+/H+ exchanger NHE1 as plasma membrane scaffold in the assembly of signaling complexes
Am J Physiol Cell Physiol,
October 1, 2004;
287(4):
C844 - C850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Pelis and J. L. Renfro
Role of tubular secretion and carbonic anhydrase in vertebrate renal sulfate excretion
Am J Physiol Regulatory Integrative Comp Physiol,
September 1, 2004;
287(3):
R491 - R501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-a. Ro and J. H. Carson
pH Microdomains in Oligodendrocytes
J. Biol. Chem.,
August 27, 2004;
279(35):
37115 - 37123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pushkin, N. Abuladze, E. Gross, D. Newman, S. Tatishchev, I. Lee, O. Fedotoff, G. Bondar, R. Azimov, M. Ngyuen, et al.
Molecular mechanism of kNBC1-carbonic anhydrase II interaction in proximal tubule cells
J. Physiol.,
August 15, 2004;
559(1):
55 - 65.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. K. Harvey, S. C. Anderson, and N. SundarRaj
Downstream Effects of ROCK Signaling in Cultured Human Corneal Stromal Cells: Microarray Analysis of Gene Expression
Invest. Ophthalmol. Vis. Sci.,
July 1, 2004;
45(7):
2168 - 2176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. B. Loiselle, P. E. Morgan, B. V. Alvarez, and J. R. Casey
Regulation of the human NBC3 Na+/HCO3- cotransporter by carbonic anhydrase II and PKA
Am J Physiol Cell Physiol,
June 1, 2004;
286(6):
C1423 - C1433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-V. Nguyen, A. Stuart-Tilley, S. L. Alper, and J. E. Melvin
Cl-/HCO3- exchange is acetazolamide sensitive and activated by a muscarinic receptor-induced [Ca2+]i increase in salivary acinar cells
Am J Physiol Gastrointest Liver Physiol,
February 1, 2004;
286(2):
G312 - G320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Weng, G. Yang, S. Weiss, and P. A. Dennery
Interaction between Heme Oxygenase-1 and -2 Proteins
J. Biol. Chem.,
December 19, 2003;
278(51):
50999 - 51005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Pelis, J. E. Goldmeyer, J. Crivello, and J. L. Renfro
Cortisol alters carbonic anhydrase-mediated renal sulfate secretion
Am J Physiol Regulatory Integrative Comp Physiol,
December 1, 2003;
285(6):
R1430 - R1438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. K. Dahl, L. Jiang, M. N. Chernova, A. K. Stuart-Tilley, B. E. Shmukler, and S. L. Alper
Deficient HCO3- Transport in an AE1 Mutant with Normal Cl- Transport Can be Rescued by Carbonic Anhydrase II Presented on an Adjacent AE1 Protomer
J. Biol. Chem.,
November 7, 2003;
278(45):
44949 - 44958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A W Cuthbert, C T Supuran, and L J MacVinish
Bicarbonate-dependent chloride secretion in Calu-3 epithelia in response to 7,8-benzoquinoline
J. Physiol.,
August 15, 2003;
551(1):
79 - 92.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|